09.05.25 -- Late-Stage Formulation Is A Different Ballgame

Discover how Cambrex is advancing peptide manufacturing with innovative liquid phase peptide synthesis (LPPS) technology, reducing costs, environmental impact, and reliance on specialized reactors. Join experts Adrian Amador and David Wang for this live webinar exploring LPPS applications, regulatory considerations, impurity control, and analytical strategies. Register today to gain insights that can accelerate your peptide development programs. Click here to learn more.

Learn more about an ex vivo cultured human skin explant model in which pathological tissue integrity, barrier function, and metabolic stability have been characterized over time.

Explore the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.

To derisk your manufacturing, work with an outsourcing partner that prioritizes the kilo lab as a space to develop a proven, robust, and reliable workflow from clinical to commercial scale.

In the pharma/biotech and medical device industries, the audit trail is important to have for accountability, data integrity, repeatability to create an event for investigation, and regulatory compliance.

Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

Testing for nitrosamines is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.

Explore the key to maintaining and enhancing existing and new partnerships as well as how outsourcing one crucial aspect of bringing products to market can benefit overall supply chain optimization.

Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

Pursue the optimization of target binders without sacrificing binding efficiency and specificity for improved drug-like characteristics. Empower the development of the most effective drug candidates.

Explore 20+ new CDMO presenters in quick 20-minute sessions during Outsourced Pharma’s October Partner Week. Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration, on-demand access, and interactive Q&A are all free.

We specialize in the custom development and manufacturing of small molecule APIs, intermediates, and RSMs, offering scalable solutions from kilograms to multi-ton quantities.

From formulation to commercial scale, our pharmaceutical manufacturing (CDMO) team provides tailored solutions for each phase of your drug development program.

ASDs are an attractive option for commercializing poorly soluble compounds. This talk focuses on capabilities to screen the potential for ASDs in early phase studies and their commercial applicability.

Our scientists specialize in formulating dissolution media with the ability to sensitively differentiate the release profiles of various drug formulations under biorelevant conditions.